مباشر

Clinical OMICsImproving HSV-2 Vaccine Efficacy with Combination Strategy CellMultimodal imaging of gene expression, morphology, and activity of the same neuron FierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violations BioWorldHangzhou Innogate Pharma discovers new KAT inhibitors BioWorldAlicorn synthesizes new AAK1 inhibitors BioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors BioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patents BioWorldNankai University and Accendatech present new majusculamide D derivatives LabiotechThe Naming Patterns Behind 12,000 Biotech Companies Endpoints NewsUS government launches probe into Germany's plan to pay less for drugs LabiotechBIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler Science Daily BiotechThis giant tropical fruit could help reverse gum disease damage

Clinical OMICs ١٩ يونيو ٢٠٢٦

Improving HSV-2 Vaccine Efficacy with Combination Strategy

Researchers at Yale explain a new strategy to improving the protective ability of an HSV-2 vaccine. Their approach combines a vaccine adjuvant to stimulate the...

Researchers at Yale explain a new strategy to improving the protective ability of an HSV-2 vaccine. Their approach combines a vaccine adjuvant to stimulate the immune system by recruiting T cells with ODNs. The post Improving HSV-2 Vaccine Efficacy with Combination Strategy appeared first on Inside Precision Medicine .